Kaitlyn D’Onofrio

DocwireNews

<p>Preclinical data suggest that a combined approach to metastatic uveal melanoma may be a viable treatment option. According to the findings, the combination of RAF/MEK inhibitor VS-6766 with focal adhesion kinase (FAK) inhibitor defactinib may be suitable for uveal melanoma patients. The <a href="https://www.abstractsonline.com/pp8/#!/9045/presentation/5323">data</a> were presented at the American Association for Cancer Research 2020 Virtual Annual Meeting II.<p>An estimated 2,500 patients are diagnosed with uveal melanoma each year, said senior investigator of the study J. Silvio Gutkind, PhD, Distinguished Professor of Pharmacology and Associate Director for Basic Science at UC San Diego Moores Cancer Center. Of these patients, about half will develop metastasis over five to 10 years, and it&rsquo;s unclear why. Survival is therefore very limited, with most patients dying between six months and one year, and conventional therapies&mdash;such as <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/common-chemotherapy-drug-less-effective-for-overweight-and-obese-individuals/">chemotherapy</a>, radiation, and surgery&mdash;are ineffective.</p><p>Dr. Gutkind discussed the findings of the study&mdash;which has been in the making since 1992&mdash;as well as what surprised him, what the future looks like for this area of research, and everything that made the study possible&mdash;in an interview with DocWire News.</p><div style="width: 1280px;" class="wp-video"><br>
<video class="wp-video-shortcode" id="video-0-1" width="1280" height="720" preload="metadata" controls="controls"><source type="video/mp4" src="https://www.docwirenews.com/wp-content/uploads/2020/07/ezgif.com-video-cutter.mp4?_=1"></source><a href="https://www.docwirenews.com/wp-content/uploads/2020/07/ezgif.com-video-cutter.mp4">https://www.docwirenews.com/wp-content/uploads/2020/07/ezgif.com-video-cutter.mp4</a></video></div></p>

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Interview: A Dual Inhibitor Approach Shows Promise in Eye Cancer

Oncology

Preclinical data suggest that a combined approach to metastatic uveal melanoma may be a viable treatment option. According to the findings, the combination of RAF/MEK ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe